MORPHGESIC

This brand name is authorized in Cyprus, United Kingdom

Active ingredients

The drug MORPHGESIC contains one active pharmaceutical ingredient (API):

1 Morphine UNII 76I7G6D29C - MORPHINE

Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation. Read about Morphine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MORPHGESIC Controlled release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AA01	Morphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 45261, 45269, 45273, 45281